J Physiol Editor in Chief
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 506, Number 3, 653-663, February 1, 1998
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vandecasteele, G.
Right arrow Articles by Fischmeister, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vandecasteele, G.
Right arrow Articles by Fischmeister, R.
The Journal of Physiology (1998), 506.3, pp. 653-663
© Copyright 1998 The Physiological Society

Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes

Grégoire Vandecasteele, Thomas Eschenhagen and Rodolphe Fischmeister

Laboratoire de Cardiologie Cellulaire et Moléculaire, INSERM U-446, Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France

  1. The whole-cell patch-clamp technique was used to examine the participation of nitric oxide synthase (NOS) and soluble guanylyl cyclase in the muscarinic regulation of the L-type Ca2+ current (ICa) in freshly isolated human atrial myocytes.

  2. Acetylcholine (ACh, 1 µM) decreased basal ICa by 39·1 ± 5·5 % (n = 8) under control conditions, and by 38·0 ± 6·1 % (n = 6) in the presence of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ, 10 µM), a potent guanylyl cyclase inhibitor, and NG-monomethyl-L-arginine (L-NMMA, 1 mM), a competitive NOS inhibitor. L-NMMA alone had no effect on ICa, whilst ODQ increased ICa in 50 % of the cells.

  3. The accentuated antagonism of ACh on ICa, i.e. its ability to antagonize the stimulatory effect of beta-adrenergic agonists and, by extension, of other cAMP-elevating agents, was examined after the current was stimulated by either the beta-adrenergic agonist isoprenaline (Iso) or serotonin (5-HT). ACh (100 nM or 1 µM) completely blocked the stimulatory effects of 10 nM Iso or 10 nM 5-HT on ICa.

  4. Extracellular application of Methylene Blue (MBlue, 10 µM), a guanylyl cyclase inhibitor, antagonized the inhibitory effect of 1 µM ACh on Iso- or 5-HT-stimulated ICa. However, this effect was overcome by a 100-fold higher ACh concentration and was not mimicked by an intracellular application of MBlue.

  5. Inhibition of NOS and soluble guanylyl cyclase activities by addition of ODQ (10 µM) and L-NMMA (1 mM) to both extracellular and intracellular solutions, or by a 2 h pre-incubation of the cells with these inhibitors, modified neither the Iso (10 nM) response nor the inhibitory effect of ACh (100 nM or 1 µM) on Iso-stimulated ICa.

  6. Extracellular application of the NO donor SNAP (S-nitroso-N-acetyl-D,L-penicillamine) at 100 nM produced a stimulatory effect on ICa in control conditions. This stimulatory effect was abolished by intracellular MBlue (20 µM) or by intracellular and extracellular application of ODQ (10 µM) in combination with L-NMMA (1 mM).

  7. We conclude that the NO-cGMP pathway does not contribute significantly to the muscarinic regulation of ICa in human atrial myocytes.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. R. Martin, K. Emanuel, C. E. Sears, Y.-H. Zhang, and B. Casadei
Are myocardial eNOS and nNOS involved in the {beta}-adrenergic and muscarinic regulation of inotropy? A systematic investigation
Cardiovasc Res, April 1, 2006; 70(1): 97 - 106.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
N. Herring, E. J. F. Danson, and D. J. Paterson
Cholinergic Control of Heart Rate by Nitric Oxide is Site Specific
Physiology, October 1, 2002; 17(5): 202 - 206.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. J. Netherton, S. L. Jimmo, D. Palmer, D. G. Tilley, H. A. Dunkerley, D. R. Raymond, J. C. Russell, P. M. Absher, E. H. Sage, R. B. Vernon, et al.
Altered Phosphodiesterase 3-Mediated cAMP Hydrolysis Contributes to a Hypermotile Phenotype in Obese JCR:LA-cp Rat Aortic Vascular Smooth Muscle Cells: Implications for Diabetes-Associated Cardiovascular Disease
Diabetes, April 1, 2002; 51(4): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. K. Choate, E. J. F. Danson, J. F. Morris, and D. J. Paterson
Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2310 - H2317.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Herring, L. Rigg, D. A Terrar, and D. J Paterson
NO-cGMP pathway increases the hyperpolarisation-activated current, If, and heart rate during adrenergic stimulation
Cardiovasc Res, December 1, 2001; 52(3): 446 - 453.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Imai, B. Jiang, and A. J Pappano
Mechanism for muscarinic inhibition of ICa(L) is determined by the path for elevating cyclic AMP in cardiac myocytes
Cardiovasc Res, August 1, 2001; 51(2): 331 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Chen, K. Spicher, M. Jiang, L. Birnbaumer, and G. T. Wetzel
Lack of muscarinic regulation of Ca2+ channels in Gi2{alpha} gene knockout mouse hearts
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1989 - H1995.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Chen
Muscarinic regulation of cardiac L-type Ca2+ current
Cardiovasc Res, December 1, 2000; 48(3): 362 - 364.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Sarkar, P. Vallance, C. Amirmansour, and S. E. Harding
Positive inotropic effects of NO donors in isolated guinea-pig and human cardiomyocytes independent of NO species and cyclic nucleotides
Cardiovasc Res, December 1, 2000; 48(3): 430 - 439.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-g. Wang, M. B. Wagner, R. W. Joyner, and R. Kumar
cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells
Cardiovasc Res, November 1, 2000; 48(2): 310 - 322.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
O.-E. Brodde and M. C. Michel
Adrenergic and Muscarinic Receptors in the Human Heart
Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Yamamoto, Y. Habuchi, H. Tanaka, F. Suto, J. Morikawa, K. Kashima, and M. Yoshimura
EP receptor-mediated inhibition by prostaglandin E1 of cardiac L-type Ca2+ current of rabbits
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1369 - H1374.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-L. Balligand
Regulation of cardiac {beta}-adrenergic response by nitric oxide
Cardiovasc Res, August 15, 1999; 43(3): 607 - 620.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. E. Sears, J. K. Choate, and D. J. Paterson
NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation
J Appl Physiol, February 1, 1999; 86(2): 510 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Poteser, C. Romanin, W. Schreibmayer, B. Mayer, and K. Groschner
S-Nitrosation Controls Gating and Conductance of the alpha 1 Subunit of Class C L-type Ca2+ Channels
J. Biol. Chem., April 27, 2001; 276(18): 14797 - 14803.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Abi-Gerges, G. Szabo, A. S. Otero, R. Fischmeister, and P.-F. Mery
NO donors potentiate the beta-adrenergic stimulation of ICa,L and the muscarinic activation of IK,ACh in rat cardiac myocytes
J. Physiol., April 15, 2002; 540(2): 411 - 424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 The Physiological Society.